The latest Investing Matters Podcast episode with London Stock Exchange Group's Chris Mayo has just been released. Listen here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHiscox Regulatory News (HSX)

Share Price Information for Hiscox (HSX)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,149.00
Bid: 1,144.00
Ask: 1,147.00
Change: 9.00 (0.79%)
Spread: 3.00 (0.262%)
Open: 1,143.00
High: 1,151.00
Low: 1,139.00
Prev. Close: 1,140.00
HSX Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Hiscox Ltd response to Supreme Court Judgment

15 Jan 2021 10:40

RNS Number : 8572L
Hiscox Ltd
15 January 2021
 

THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION

 

Hiscox Ltd response to Supreme Court Judgment in Insurance Industry Test Case

 

Hamilton, Bermuda (15 January 2021) - Hiscox Ltd (LSE:HSX), the international specialist insurer, notes the judgment of the Supreme Court (the "Judgment") delivered today in the appeal of the UK insurance industry test case on the contractual interpretation of business interruption wordings in certain UK property insurance policies (the "Industry Test Case").

 

Key points:

 

· Hiscox welcomes the clarity of final Judgment; claims settlement process has begun

· The outcome of the Supreme Court's Judgment confirms that fewer than one third of Hiscox's 34,000 UK Business Interruption policies may respond

· Hiscox Group 2020 COVID-19 estimate for business interruption increased by $48 million net of reinsurance

· Hiscox's capital position remains strong and the Group maintains an "A" rating for financial strength from S&P.

 

In order to achieve clarity for customers on the application of relevant policies as quickly as possible, Hiscox agreed in May 2020 to assist the Financial Conduct Authority ("FCA") by participating in the Industry Test Case alongside seven other insurers. Following the ruling handed down by the High Court in September 2020, permission to appeal to the Supreme Court was granted to the FCA, a policyholder group and six insurers, including Hiscox.

 

The Judgment handed down today comprises more than 100 pages of legal analysis by the Supreme Court addressing important points of insurance law and setting new precedent for over 50 insurers and almost 400,000 policyholders. The Supreme Court largely confirms the outcome of the High Court's ruling that, except in rare circumstances, cover is restricted to Hiscox policyholders who were mandatorily closed. Fewer than one third of Hiscox's 34,000 UK Business Interruption policies may respond as a result.

 

The Judgment represents the final outcome of the Industry Test Case, and there can be no further appeals. Hiscox welcomes the clarity that the Judgment provides and the processing of claims has begun.

 

As a result of the Judgment as well as further government restrictions announced during 2020, the total Hiscox Group 2020 COVID-19 estimate for business interruption increased by $48 million net of reinsurance. In addition the previously disclosed additional loss estimate of up to $40 million for event cancellation if government restrictions continued into 2021, will now be recognised in our 2020 financial result due to the expectation that covered events will be cancelled.

 

As previously stated, Hiscox's exposure to potential business interruption claims arising from further UK government restrictions to contain the spread of COVID-19 has been running off at approximately 8% per month from June 2020, with residual exposure to be fully run off by the end of June 2021. Following the Judgment, the Group estimates exposure to restrictions already announced in 2021 at less than $20 million if restrictions extend to the end of March.

 

The Group remains focused on supporting its customers and employees through this challenging period. It continues to deploy capital for growth in an improving market. Hiscox's capital position remains strong and the Group maintains an "A" rating for financial strength from S&P. The Group will provide a comprehensive update of its performance in its preliminary results announcement on 3 March 2021.

 

The person responsible for arranging and authorising the release of this announcement on behalf of the Company is Marc Wetherhill, Group Company Secretary.

 

 

ENDS

 

For further information:

Marc Wetherhill, Group Company Secretary, Bermuda +1 441 278 8321

Yana O'Sullivan, Head of Investor Relations, London +44 (0)20 3321 5598

Kylie Thompson, Group Communications Director, London +44 (0)20 74448 6656

 

Brunswick

Tom Burns +44 (0)20 7404 5959

Simone Seizer +44 (0)20 7404 5959

 

Notes to editors

Hiscox response to Covid-19: staff and society

Hiscox is committed to supporting the international response to this pandemic. The Group has over 95% of employees around the world working from home, and is supporting them through flexible working and the provision of mental health and wellbeing services. Wherever possible operations have been reorganised to deploy more employees to provide customer support. Hiscox is not furloughing any staff, and has not accessed any government support schemes.

 

Hiscox is working with the rest of the insurance industry through the Association of British Insurers', COVID-19 Support Fund to direct financial support to where it will have the most impact. Through the Hiscox Foundation, the Group is also supporting vulnerable groups via donations to established charities such as the Trussell Trust and Age UK and around the world we have donated to food banks, the Red Cross and Personal Protective Equipment (PPE) funds.

 

About the Hiscox Group

Hiscox is a global specialist insurer, headquartered in Bermuda and listed on the London Stock Exchange (LSE:HSX). Our ambition is to be a respected specialist insurer with a diverse portfolio by product and geography. We believe that building balance between catastrophe-exposed business and less volatile local specialty business gives us opportunities for profitable growth throughout the insurance cycle. 

 

The Hiscox Group employs over 3,000 people in 14 countries, and has customers worldwide. Through the retail businesses in the UK, Europe, Asia and the USA, we offer a range of specialist insurance for professionals and business customers as well as homeowners. Internationally traded, bigger ticket business and reinsurance is underwritten through Hiscox London Market and Hiscox Re & ILS.

 

Our values define our business, with a focus on people, courage, ownership and integrity. We pride ourselves on being true to our word and our award-winning claims service is testament to that. For more information, visit www.hiscoxgroup.com.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCBELFFFFLXBBE
Date   Source Headline
15th May 20207:00 amRNSAGM Results
14th May 20202:06 pmRNSDirector/PDMR Shareholding
13th May 20204:20 pmRNSTR-1: Standard form-notification of major holdings
13th May 20208:53 amRNSTR-1: Standard form-notification of major holdings
11th May 20202:40 pmRNSTR-1: Standard form-notification of major holdings
6th May 20205:30 pmRNSHiscox
6th May 20207:00 amRNSResults of capital raise
5th May 20204:35 pmRNSProposed capital raise of ordinary shares
5th May 20204:35 pmRNSHiscox Ltd trading statement
4th May 20207:00 amRNSSyndicates 33 and 6104 – results and estimates
1st May 202012:29 pmRNSTotal Voting Rights
29th Apr 20207:00 amRNSResponse to press speculation
22nd Apr 20207:00 amRNSMarket update on COVID-19 exposure
15th Apr 20202:20 pmRNSMarket update re business interruption exposure
14th Apr 20202:38 pmRNSNotice of 2020 Annual General Meeting
8th Apr 20207:00 amRNSUpdate on dividend payment and guidance
1st Apr 202012:07 pmRNSTotal Voting Rights
1st Apr 20207:00 amRNSDirector/PDMR Shareholding
16th Mar 20201:08 pmRNSDirector/PDMR Shareholding
11th Mar 20202:36 pmRNSAnnual Report
5th Mar 20207:00 amRNSDirector/PDMR Shareholding
2nd Mar 20203:38 pmRNSChief Underwriting Officer
2nd Mar 202012:50 pmRNSSyndicates 33 and 6104 – results and estimates
2nd Mar 20207:01 amRNSHiscox Ltd full year results
6th Jan 202010:06 amRNSTR-1: Standard form-notification of major holdings
2nd Jan 20201:13 pmRNSTotal Voting Rights
17th Dec 20192:33 pmRNSNotification of transactions
2nd Dec 20191:15 pmRNSTotal Voting Rights
13th Nov 20197:00 amRNSDirector/PDMR Shareholding
11th Nov 20195:12 pmRNSTR-1: Standard form-notification of major holdings
7th Nov 20192:08 pmRNSHiscox Ltd market announcement
4th Nov 20197:01 amRNSHiscox Ltd Q3 Trading Statement
4th Nov 20197:00 amRNSSyndicates 33 and 6104 - estimates
1st Nov 20193:27 pmRNSTotal Voting Rights
1st Oct 20194:39 pmRNSDirector/PDMR Shareholding
1st Oct 20194:30 pmRNSTotal Voting Rights
20th Sep 20192:35 pmRNSDirector/PDMR Shareholding
18th Sep 20194:18 pmRNS2020 Syndicate Business Forecast
17th Sep 20195:35 pmRNSDirector/PDMR Shareholding
13th Sep 20195:16 pmRNSDirector/PDMR Shareholding
9th Sep 20191:15 pmRNSApplication to be Admitted to Official List
5th Sep 20197:00 amRNSAppointment of Group Chief Underwriting Officer
3rd Sep 20192:40 pmRNSTotal Voting Rights
27th Aug 20194:06 pmRNSAnnouncement of Scrip Reference Share Price
20th Aug 20193:35 pmRNSDirector/PDMR Shareholding
19th Aug 20195:28 pmRNSTR-1: Standard form-notification of major holdings
7th Aug 20191:21 pmRNSDirector/PDMR Shareholding
2nd Aug 201911:40 amRNSTotal Voting Rights
1st Aug 20192:33 pmRNSApplication for Block Listing
1st Aug 20197:00 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.